SciELO - Scientific Electronic Library Online

 
vol.36 número 2Espondilodiscitis Bacteriana Inespecífica: una afección con incidencia crecienteCuando el motivo de consulta son las palpitaciones, ¿cómo continuar? índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Links relacionados

Compartir


Archivos de Medicina Interna

versión impresa ISSN 0250-3816versión On-line ISSN 1688-423X

Resumen

MENENDEZ, Josemaría et al. Diagnosis and therapy of Hepatocarcinoma: update of the topic and the internist’s role. Arch. Med Int [online]. 2014, vol.36, n. 2, pp.60-65. ISSN 0250-3816.

Hepatocellular carcinoma is the most common malignant liver tumor, the 5th most prevalent worldwide and the 3rd leading cause of death from cancer. Over 90% of cases are associated with cirrhosis, the incidence in this population is 3 to 5%, been the leading cause of death in this population. It is expected that the incidence would increase in the next 2 decades. In recent years new diagnostic and therapeutic strategies have been developed, that have dramatically changed the treatment strategies in early stages of the disease. As this tumor develops primarily in cirrhotic patients, where the global management of the patient is crucial, the Internist plays a fundamental role in the proper approach. Tasks such as prevention, surveillance, early diagnosis and multi and interdisciplinary approach, in the different stages of the disease, are just some of the most relevant aspects. The interaction between physician and Hepatologist is essential, working together to define the different actions in pre-and post-treatment phases.

Palabras clave : Hepatocellular carcinoma; Surveillance; Screening; Radiofrequency ablation; Percutaneous ethanol injection; Transarterial chemoembolization; Liver transplantation; Review.

        · resumen en Español     · texto en Español

 

Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons